Brenda Cooper
- Genetics top 0.5%
- Hematology top 0.5%
- Oncology top 5%
- Molecular Biology top 10%
- Surgery top 5%
- Co-authors
- Hillard M. LazarusStanton L. GersonOmer N. KoçStephen E. HaynesworthArnold I. CaplanMary J. LaughlinRichard J. CregerH. Kent Holland
- Topics
- Lymphoma Diagnosis and Treatment (35 papers)Acute Myeloid Leukemia Research (34 papers)Hematopoietic Stem Cell Transplantation (31 papers)
- Cited by
- GeneticsHematologyOncology
- Partner nations
- United StatesCanadaIreland
In The Last Decade
Brenda Cooper
126 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Genetics 1.6k
- Hematology 1.2k
- Oncology 799
- Molecular Biology 739
- Surgery 553
Countries citing papers authored by Brenda Cooper
This map shows the geographic impact of Brenda Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda Cooper more than expected).
Fields of papers citing papers by Brenda Cooper
This network shows the impact of papers produced by Brenda Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda Cooper. The network helps show where Brenda Cooper may publish in the future.
Co-authorship network of co-authors of Brenda Cooper
This figure shows the co-authorship network connecting the top 25 collaborators of Brenda Cooper. A scholar is included among the top collaborators of Brenda Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda Cooper. Brenda Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 27 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 2 | |
| 11 | 42 | |
| 12 | 17 | |
| 13 | 54 | |
| 14 | 14 | |
| 15 | 21 | |
| 16 | 22 | |
| 17 | 9 | |
| 18 | 11 | |
| 19 | 3 | |
| 20 | 5 |
About Brenda Cooper
Brenda Cooper is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 133 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (35 papers), Acute Myeloid Leukemia Research (34 papers) and Hematopoietic Stem Cell Transplantation (31 papers). The work is most often cited by research in Genetics (1.6k citations), Hematology (1.2k citations) and Oncology (799 citations). Brenda Cooper has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Hillard M. Lazarus, Stanton L. Gerson, Omer N. Koç, Stephen E. Haynesworth, Arnold I. Caplan, Mary J. Laughlin, Richard J. Creger, H. Kent Holland, Philip L. McCarthy and Andrea Bacigalupo. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.